Literature DB >> 21146605

Polycystic kidney disease: pathogenesis and potential therapies.

Vinita Takiar1, Michael J Caplan.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent, inherited condition for which there is currently no effective specific clinical therapy. The disease is characterized by the progressive development of fluid-filled cysts derived from renal tubular epithelial cells which gradually compress the parenchyma and compromise renal function. Current interests in the field focus on understanding and exploiting signaling mechanisms underlying disease pathogenesis as well as delineating the role of the primary cilium in cystogenesis. This review highlights the pathogenetic pathways underlying renal cyst formation as well as novel therapeutic targets for the treatment of PKD. This article is part of a Special Issue entitled: Polycystic Kidney Disease.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21146605      PMCID： PMC3139769          DOI： 10.1016/j.bbadis.2010.11.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


  152 in total

Review 1.  The ciliary membrane.

Authors:  Rajat Rohatgi; William J Snell
Journal:  Curr Opin Cell Biol       Date:  2010-04-17       Impact factor: 8.382

2.  A motility in the eukaryotic flagellum unrelated to flagellar beating.

Authors:  K G Kozminski; K A Johnson; P Forscher; J L Rosenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

3.  Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.

Authors:  Andreas L Serra; Diane Poster; Andreas D Kistler; Fabienne Krauer; Shagun Raina; James Young; Katharina M Rentsch; Katharina S Spanaus; Oliver Senn; Paulus Kristanto; Hans Scheffel; Dominik Weishaupt; Rudolf P Wüthrich
Journal:  N Engl J Med       Date:  2010-06-26       Impact factor: 91.245

4.  Everolimus in patients with autosomal dominant polycystic kidney disease.

Authors:  Gerd Walz; Klemens Budde; Marwan Mannaa; Jens Nürnberger; Christoph Wanner; Claudia Sommerer; Ulrich Kunzendorf; Bernhard Banas; Walter H Hörl; Nicholas Obermüller; Wolfgang Arns; Hermann Pavenstädt; Jens Gaedeke; Martin Büchert; Christoph May; Harald Gschaidmeier; Stefan Kramer; Kai-Uwe Eckardt
Journal:  N Engl J Med       Date:  2010-06-26       Impact factor: 91.245

5.  Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models.

Authors:  Thomas A Natoli; Laurie A Smith; Kelly A Rogers; Bing Wang; Svetlana Komarnitsky; Yeva Budman; Alexei Belenky; Nikolay O Bukanov; William R Dackowski; Hervé Husson; Ryan J Russo; James A Shayman; Steven R Ledbetter; John P Leonard; Oxana Ibraghimov-Beskrovnaya
Journal:  Nat Med       Date:  2010-06-20       Impact factor: 53.440

6.  Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease.

Authors:  A B Chapman; A M Johnson; P A Gabow; R W Schrier
Journal:  J Am Soc Nephrol       Date:  1994-12       Impact factor: 10.121

7.  Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome.

Authors:  P T Brook-Carter; B Peral; C J Ward; P Thompson; J Hughes; M M Maheshwar; M Nellist; V Gamble; P C Harris; J R Sampson
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

8.  Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.

Authors:  C J Sabers; M M Martin; G J Brunn; J M Williams; F J Dumont; G Wiederrecht; R T Abraham
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

9.  Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia.

Authors:  Christopher J Ward; David Yuan; Tatyana V Masyuk; Xiaofang Wang; Rachaneekorn Punyashthiti; Shelly Whelan; Robert Bacallao; Roser Torra; Nicholas F LaRusso; Vicente E Torres; Peter C Harris
Journal:  Hum Mol Genet       Date:  2003-08-12       Impact factor: 6.150

10.  The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease.

Authors:  Robert W Schrier; Ann M Johnson; Kim McFann; Arlene B Chapman
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612
View more
  32 in total

1.  The role of simple renal cysts, abdominal wall hernia, and chronic obstructive pulmonary disease as predictive factors for aortoiliac aneurysmatic disease.

Authors:  Georgios A Pitoulias; Konstantinos P Donas; Grigoris Chatzimavroudis; Giovanni Torsello; Dimitrios K Papadimitriou
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

2.  Polycystin-1 regulates bone development through an interaction with the transcriptional coactivator TAZ.

Authors:  David Merrick; Kavita Mistry; Jingshing Wu; Nikolay Gresko; Julie E Baggs; John B Hogenesch; Zhaoxia Sun; Michael J Caplan
Journal:  Hum Mol Genet       Date:  2019-01-01       Impact factor: 6.150

Review 3.  Autophagy and regulation of cilia function and assembly.

Authors:  I Orhon; N Dupont; O Pampliega; A M Cuervo; P Codogno
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

Review 4.  Polycystic liver diseases: advanced insights into the molecular mechanisms.

Authors:  Maria J Perugorria; Tatyana V Masyuk; Jose J Marin; Marco Marzioni; Luis Bujanda; Nicholas F LaRusso; Jesus M Banales
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-09-30       Impact factor: 46.802

5.  Primary-cilium-dependent autophagy controls epithelial cell volume in response to fluid flow.

Authors:  Idil Orhon; Nicolas Dupont; Mohamad Zaidan; Valérie Boitez; Martine Burtin; Alain Schmitt; Thierry Capiod; Amandine Viau; Isabelle Beau; E Wolfgang Kuehn; Gérard Friedlander; Fabiola Terzi; Patrice Codogno
Journal:  Nat Cell Biol       Date:  2016-05-23       Impact factor: 28.824

6.  Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.

Authors:  Ao Li; Xin Tian; Xiaoli Zhang; Shunwei Huang; Yujie Ma; Dianqing Wu; Gilbert Moeckel; Stefan Somlo; Guanqing Wu
Journal:  Am J Pathol       Date:  2015-10       Impact factor: 4.307

Review 7.  Predictors of autosomal dominant polycystic kidney disease progression.

Authors:  Robert W Schrier; Godela Brosnahan; Melissa A Cadnapaphornchai; Michel Chonchol; Keith Friend; Berenice Gitomer; Sandro Rossetti
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

8.  VIP17/MAL expression modulates epithelial cyst formation and ciliogenesis.

Authors:  Vinita Takiar; Kavita Mistry; Monica Carmosino; Nicole Schaeren-Wiemers; Michael J Caplan
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-15       Impact factor: 4.249

Review 9.  Polycystin-1 cleavage and the regulation of transcriptional pathways.

Authors:  David Merrick; Claudia A Bertuccio; Hannah C Chapin; Mark Lal; Veronique Chauvet; Michael J Caplan
Journal:  Pediatr Nephrol       Date:  2013-07-04       Impact factor: 3.714

10.  Inactivation of max-interacting protein 1 induces renal cilia disassembly through reduction in levels of intraflagellar transport 20 in polycystic kidney.

Authors:  Je Yeong Ko; Kyung Hyun Yoo; Seon Ah Song; Do Yeon Kim; Hyun Kyung Kong; Curie Ahn; Han Woong Lee; Duk-Hee Kang; Goo Taeg Oh; Jong Hoon Park
Journal:  J Biol Chem       Date:  2013-01-13       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.